NEO100 and High-Grade Meningioma
Trial details
- Registry ID
- NCT05023018
- Drugs studied
- NEO100
TrialRedline tracks 1 clinical trial sponsored by Neonc Technologies, Inc.: 1 Phase 2.
Company identity has not yet been verified
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| NEO100 and High-Grade MeningiomaNCT05023018 | NEO100 | Recruiting | 2026-12-30Estimated |
Names as written in the registry records.
NCT05023018 · Neonc Technologies, Inc.
Before: 30 Sep 2025. After: 30 Dec 2026.